External validation of a measurement tool to assess systematic reviews (AMSTAR)

PLoS ONE

Volumn 2, Issue 12, 2007, Pages

  Shea, Beverley J ^a,b   Bouter, Lex M ^c   Peterson, Joan ^d   Boers, Maarten ^c   Andersson, Neil ^a,e   Ortiz, Zulma ^f   Ramsay, Tim ^d   Bai, Annie ^g   Shukla, Vijay K ^g   Grimshaw, Jeremy M ^d  

^a Community Information and Epidemiological Technologies ^*  (Canada)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

^d OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^e UNIVERSIDAD AUTÓNOMA DE GUERRERO   (Mexico)

^f ACADEMIA NACIONAL DE MEDICINA   (Argentina)

^g CANADIAN AGENCY FOR DRUGS AND TECHNOLOGIES IN HEALTH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

A MEASUREMENT TOOL TO ASSESS SYSTEMATIC REVIEWS; CONFIDENCE INTERVAL; CONSTRUCT VALIDITY; EXTERNAL VALIDITY; GASTROESOPHAGEAL REFLUX; HEALTH CARE; KAPPA STATISTICS; MEASUREMENT; METHODOLOGY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PEPTIC ULCER; RELIABILITY; REVIEW; SCORING SYSTEM; ARTICLE; HUMAN; META ANALYSIS; REPRODUCIBILITY; STOMACH ACID; VALIDATION STUDY;

GASTRIC ACID; GASTROESOPHAGEAL REFLUX; HUMANS; META-ANALYSIS AS TOPIC; PEPTIC ULCER; REPRODUCIBILITY OF RESULTS;

EID: 44349182040     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0001350     Document Type: Review

References (70)

1. Young D (2005) Policymakers, experts review evidence-based medicine. Am. J. Health Syst Pharm 62(4): 342-343.
2. Dolan-Mullen P, Ramirez G (2006) The Promise and Pitfalls of Systematic Reviews. Annual Review of Public Health 27: 81-102.
3. Oxman AD, Guyatt GH (199 1) Validation of an index of the quality of review articles. J Clin Epidemiol 44(11): 1271-78.
4. Moher D Jadad AR, Nichol G, Penman M, Tugwell P, et al. (1995) Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. Control Clin Trials 16(1): 62-73.
5. Shea B, Dube C, Moher D (2001) Assessing the quality of reports of systematic reviews: the QUOROM statement compared to other tools. Systematic review in health care meta-analysis in context. London: BMJ Books (7): 122-39.
6. Shea B (1999) Assessing the quality of reporting meta-analyses of randomized controlled trials, MSc thesis. University of Ottawa, Department of Epidemiology and Community Medicine.
7. Shea B, Grimshaw JM, Wells GA, Boers M, Andersson N, et al. (2007) Development of AMSTAR: A Measurement Tool to Assess Systematic Reviews. BMC Medical Research Methodology 7: 10, doi: 10. 1186/1471-2288-7-10.
8. Singh S, Bai A, Lal A, Yu C, Ahmed F, et al. (2006) Developing evidence-based best practices for the prescribing and use of proton pump inhibitors in Canada. Ottawa, Canada: The Canadian Agency for Drugs and Technologies in Health (CADTH).
9. Chiba N, De Cara CJ, Wilkinson JM, Hunt RH (1997) Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology 112(6): 1798-810.
10. Carol JJ, Salas M, Ward A (2001) Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials. Clin Ther 23(7): 998-1017.
11. Klok RM, Postma MJ, van Hout BA, Brouwers JR (2003) Meta-analysis: comparing the efficacy of proton pump inhibitors in short-term use. Aliment Pharmacol Ther 17(10): 1237-45.
12. Van Pinxteren B, Numans ME, Lau J, de Wit NJ, Hungin AP, et al. (2003) Short-term treatment of gastroesophageal reflux disease. J Gen Intern Med 18(9): 755-63.
13. Van Pinxteren B, Numans ME, Bonis PA, Lau J (2004) Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database Syst Rev (3): CD002095.
14. Rostom A, Dube C, Wells G, Tugwell P, Welch V, et al. (2002) Prevention of NSAID-induced gastroduodenal ulcers. Cochrane Database Syst Rev (4): CD002296.
15. Laheij RJ, van Rossum LG, Jansen JB, Straatman H, Verbeek AL (1999) Evaluation of treatment regimens to cure Helicobacter pylori infection: a meta-analysis. Aliment Pharmacol Ther 13(7): 857-64.
16. Carlsson R, Galmiche JP, Dent J, Lundell L, Frison L (1997) Prognostic factors influencing relapse of oesophagitis during maintenance therapy with aritisecretory drugs: a meta-analysis of long-term omeprazole trials. Aliment Pharmacol Ther 11(3): 473-82.
17. Chiba N (1997) Proton pump inhibitors in acute healing and maintenance of erosive or worse esophagitis: a systematic overview. Can J Gastroenterol II Suppl B: 66B-73B.
18. Delaney B, Moayyedi P, Deeks J, Innes M, Soo S, et al. (2000) The management or dyspepsia: a systematic review. Health Technol Assess 4(39); i,iii-189. Available: http://www.ncchta.org/execsumm/summ439,htm.
19. Moayyedi P, Soo S, Deeks J, Delaney B, Harris A, et al. (2005) Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev (1): CD002096.
20. Moayyedi P, Soo S, Deeks J, Delaney B, Innes M, et al. (2005) Pharmacological inter-ventions for non-ulcer dyspepsia. Cochrane Database Syst Rev (1): CD001960, Available: http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD001960/pdf_fs.html (accessed 2006 Feb 16).
21. Delaney BC, Moayyedi P, Forman D (2003) Initial management strategies for dyspepsia. Cochrane Database Syst Rev (2): CD001961.
22. Hopkins RJ, Girardi LS, Turney EA (1996) Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology 110(4): 1244-52.
23. Huang JQ, Sridhar S, Hunt RH (2002) Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet 359(9300): 14-22.
24. Moayyedi P, Soo S, Deeks J, Forman D, Mason J, et al. (2000) Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group. BMJ 321(7262): 659-64.
25. Jovell AJ, Aymerich M, Garcia Altes A, Serra Prat M (1998) Clinical practice guideline for the eradicating therapy of Helicobacter pylori infections associated to duodenal ulcer in primary care. Barcelona: Catalan Agency for Health Technology Assessment. Available: http://www.gencat.net/salut/depsan/units/aatrm/pdf/gp9802en.pdf.
26. Gisbert JP, González L, Calvet X, Garcia N, López T (2000) Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori. Aliment Pharmacol Ther 14(10): 1319-28.
27. Calvet X Garcia N, López T, Gisbert JP, Gené E, et al. (2000) A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or annoxycillin for treating Helicobacter pylori infection. Aliment Pharmacol Ther 14(5): 603-09.
28. Gené E, Calvet X, Azagra R, Gisbert JP (2003) Triple vs. quadruple therapy for treating Helicobacter pylori infection: a meta-analysis. Aliment Pharmacol Ther 17(9): 1137-43.
29. Huang J, Hunt RH (1999) The importance of clarithromycin dose in the management of Helicobacter pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and annoxycillin or metronidazole. Aliment Pharmacol Ther 13(6): 719-29.
30. Leodolter A, Kulig M, Brasch H, Meyer Sabellek W, Willich SN, et al. (2001) A meta-analysis comparing eradication, healing and relapse rates in patients with Helicobacter pylori-associated gastric or duodenal ulcer. Aliment Pharmacol Ther 15(12): 1949-58.
31. Moayyedi P, Murphy B (2001) Helicobacter pylori: a clinical update. J Appl Microbiol (30): 126S-33S.
32. Oderda G, Rapa A, Bona G (2000) A systematic review of Helicobacter pylori eradication treatment schedules in children. Aliment Pharmacol Ther 14(Suppl 3): 59-66.
33. Schmid CH, Whiting G, Cory D, Ross SD, Chalmers TC (1999) Omeprazole plus antibiotics in the eradication of Helicobacter pylori infection: a meta-regression analysis of randomized, controlled trials. Am J Ther 6(1): 25-36.
34. Unge P, Berstad A (1996) Pooled analysis or anti-Helicobacter pylori treatment regimens. Scand J Gastroenterol Suppl 220: 27-40.
35. Unge, P (1998) Antimicrobial treatment of H. pylori infection: a pooled efficacy analysis of eradication therapies. Eur J Surg Suppl 582: 16-26.
36. Unge P (1997) What other regimens are under investigation to treat Helicobacter pylori infection? Gastroenterology 113(6 Suppl): S131-S148.
37. Vallve M, Vergara M, Gisbert JP, Calvet X (2002) Single vs, double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta-analysis. Aliment Pharmacol Their 16(6): 1149-56.
38. Veldbuyzen van Zanten SJ, Sherman PM (1994) Indications for treatment of Helicobacter pylori infection: a systematic overview. CMAJ 150(2): 189-98.
39. Trépanier EF, Agro K, Holbrook AM, Blackhouse G, Goeree R, et al. (1998) Meta-analysis of H pylori (HP) eradication rates in patients with duodenal ulcer (DU). Can J Clin Pharmacol. 5(1): 67.
40. Bamberg P, Caswell CM, Frame MH, Lam SK, Wong EC (1992) A meta-analysis comparing the efficacy of omeprazole with H2-receptor antagonists for acute treatment or duodenal ulcer in Asian patients. J Gastroenterol Hepatol 7(6): 577-85.
41. Di Mario F, Battaglia G, Leandro G, Grasso G, Vianello F, et al. (1996) Shortterm treatment of gastric ulcer: a meta-analytical evaluation or blind trials. Dig Dis Set 41(6): 1108-31.
42. Eriksson S, Langstrom G, Rikner L, Carlsson R, Naesdal J (1995) Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and rellux oesophagitis: a meta-analysis. Eur J Gastroenterol Hepatol 7(5): 467-75.
43. Poynard T, Lemaire M, Agostini H (1995) Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer. Eur J Gastroenterol Hepatol 7(7): 661-65.
44. Laine L, Schoenfeld P, Fennerty MB (2001) Therapy for Helicobacter pylori in patients with nonulcer dyspepsia: a meta-analysis of randomized, controlled trials. Ann Intern Med 134(5): 361-9.
45. Mulder CJ, Schipper DL (1990) Omeprazole and ranitidine in duodenal ulcer healing. Analysis of comparative clinical trials. Scand J Gastroenterol Suppl 178: 62-6.
46. Shiau JY, Shukla VK, Dubé C (2002) The efficacy of proton pump inhibitors in adults with functional dyspepsia. Ottawa: Canadian Coordinating Office for Health Technology Assessment.
47. Danesh J, Lawrence M, Murphy M, Roberts S, Collins R (2005) Systematic review of the epidemiological evidence on Helicobacter pylori infection and non-ulcer or uninvestigated dyspepsia. Arch Intern Med 160(8): 1192-98.
48. Gibson PG, Henry RL, Coughlan JL (2005) Gastro-esophageal reflux treatment for asthma in adults and children. Cochrane Database Syst Rev (3): 1-27.
49. Fischbach LA, Goodman KJ, Feldman M, Aragaki C (2002) Sources of variation of helicobacter pylori treatment success in adults worldwide: a meta-analysis. Int J Epidemic 31(1): 128-39.
50. Ford A, Delaney B, Moayyedi P (2003) Eradication therapy for peptic ulcer disease in helicobacter pylori positive patients. Cochrane Database Syst Rev (4): CD003840.
51. Oxman AD, Guyatt GH (1991) Validation of an index of the quality of review articles. J Clin Epidemiol 44(11): 1271-78.
52. Cohen J (1960) A coefficient of agreement for nominal scales. Educ Psychol Measure 0(1): 622-26.
53. Bland JM, Altman DC (1986) Statistical methods for assessing agreement between two methods of clinical Measurement. Lancet i: 307-10.
54. Bland JM, Altman DG (1987) Statistical methods for assessing agreement between measurement. Biochimica Clinica 11: 399-404.
55. Meade M, Cook R, Guyatt G, Groll R, Kachura J, et al. (2000) Interobserver Variation in Interpreting Chest Radiographs for the Diagnosis of Acute Respiratory Distress Syndrome. Am J Respir. Crit. Care Med 161(1): 185-90.
56. Uebersax JS (1987) Diversity of decision-making models and the measurement of inter-rater agreement. Psychological Bulletin 101: 140-46.
57. Cohen J (1968) Weighted kappa: Nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull 70: 213-220.
58. McGinn T, Guyatt G, Cook R, Meade M (2002) Diagnosis: measuring agreement beyond chance. In: Guyatt G, Rennie D, eds. Users' guide to the medical literature. A manual for evidence-based clinical practice. Chicago, IL: AMA Press. pp 461-70.
59. Moja LP, Telaro E, D'Amico R, Moschetti I, Coe L, et al. (2005) Assessment of methodological quality of primary studies by systematic reviews: results or the metaquality cross sectional study. BMJ Publishing Group Ltd. 330(7499): 1053.
60. Shea B, Moher D, Graham I, Pham B, Tugwell P (2002) A comparison of the quality of Cochrane reviews and systematic reviews published in paper-based journals. Evaluation & the Health Professions 25(1): 116-29.
61. Moher D, Tetzlaff J, Tricco AC, Sampson M, Altman DG (2007) Epidemiology and Reporting Characteristics of Systematic Reviews. PLoS Med 4(3): e78, doi: 10. 1371/journal.pmed.0040078.
62. Sacks HS, Berrier J, Reitman D, Ancona-Berk VA, Chalmers TC (1987) Meta-analyses of randomized controlled trials. New England Journal of Medicine 316: 450-54.
63. Bero LA (2005) Managing financial conflicts of interest in research. Journal of the American College of Dentists 72(2): 4-9.
64. Biondi-Zoccai G, Lotrionte M, Abbate A, Testa L (2006) Compliance with QUOROM and quality of reporting of overlapping meta-analyses on the role of acetylcysteine in the prevention of contrast associated nephropathy: case study, BMJ 332: 202-6.
65. Fleiss JL (1971) Measuring nominal scale agreement among many raters. Psychol. Bull 76: 378-382.
66. McClure M, Willett W (1987) Misinterpretation and misuse of the kappa statistic. Am. J. Epidemiol. 126: 161-169.
67. Cook RJ, Farewell VT (1995) Conditional inference for subject-specific and marginal agreement: two families of agreement measures. Can. J. Stat 23: 333-344.
68. Barnes DE, Bero, LA (1998) Why review articles on the health effects of passive smoking reach different conclusions. JAMA 279: 1566-1570.
69. Cho MK, Bero LA (1996) The quality of drug studies published in symposium proceedings. Ann Intern Med 124: 485-489.
70. Lexchin J, Bero LA, Djulbegovic B, Clark O (2003) Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 326: 1167-1170.